title: Harmonization of Renal Function Assessment Is Needed During Early Clinical Development of Oncology Drugs.
authors.affiliation: Johns Hopkins University, Baltimore, MD mrudek2@jhmi.edu.
authors.forename: Michelle A
authors.initials: MA
authors.lastname: Rudek
authors.affiliation: Theravance Biopharma, South San Francisco, CA.
authors.forename: Richard A
authors.initials: RA
authors.lastname: Graham
authors.affiliation: University of Chicago, Chicago, IL.
authors.forename: Mark J
authors.initials: MJ
authors.lastname: Ratain
mesh_terms: D000970:Antineoplastic Agents / Q000009:adverse effects* / Q000493:pharmacokinetics*; D017321:Clinical Trials, Phase I as Topic / Q000706:statistics & numerical data*; D003404:Creatinine / Q000378:metabolism*; D005260:Female; D006801:Humans; D007668:Kidney / Q000187:drug effects*; D008297:Male; D018579:Patient Selection; D051436:Renal Insufficiency, Chronic / Q000378:metabolism*
chemical_list: D000970:Antineoplastic Agents; D003404:Creatinine